Table 2 Angiographic and procedural characteristics
NPR on aspirin (n = 1240) | HPR on aspirin (n = 91) | P value | NPR on clopidogrel (n = 891) | HPR on clopidogrel (n = 437) | P value | |
|---|---|---|---|---|---|---|
Multi-vessel disease, n (%) | 517 (59.2) | 41 (63.1) | 0.601 | 363 (59.6) | 194 (59.1) | 0.889 |
Bifurcation lesion, n (%) | 407 (32.8) | 35 (38.5) | 0.300 | 301 (33.8) | 141 (32.3) | 0.578 |
Thrombus-containing lesions, n (%) | 113 (9.3) | 5 (5.7) | 0.336 | 77 (8.9) | 41 (9.5) | 0.683 |
IIb/IIIa Inhibitor, n (%) | 122 (10.8) | 7 (8.6) | 0.709 | 96 (12.0) | 33 (8.2) | 0.048 |
DES used, n (%) | 1240 (100) | 91 (100) | NS | 891 (100) | 437 (100) | NS |
Total implanted stent | 2.78 ± 1.72 | 2.58 ± 1.61 | 0.287 | 2.81 ± 1.76 | 2.69 ± 1.62 | 0.235 |
Mean stent diameter, mm | 3.08 ± 0.38 | 3.03 ± 0.34 | 0.313 | 3.08 ± 0.38 | 3.05 ± 0.39 | 0.155 |
Total stent length, mm | 72.14 ± 48.69 | 65.06 ± 42.73 | 0.187 | 72.61 ± 49.14 | 69.77 ± 46.65 | 0.332 |
Complete revascularization, n (%) | 823 (67.9) | 59 (67.0) | 0.906 | 598 (68.8) | 281 (65.7) | 0.256 |
Final TIMI grade 3, n (%) | 1199 (98.2) | 88 (98.9) | NS | 860 (98.3) | 424 (98.1) | 0.827 |
Heparin volume, units | 7915.11 ± 2027.05 | 8085.00 ± 1945.01 | 0.503 | 7892.79 ± 2029.11 | 7999.97 ± 2012.82 | 0.421 |